UBS Maintains Buy on Visteon, Lowers Price Target to $107

Benzinga Newsdesk www.benzinga.com Negative 70.2%

Neg 70.2% Neu 0% Pos 0%

UBS analyst Joseph Spak maintains Visteon (NASDAQ:VC) with a Buy and lowers the price target from $130 to $107.

Comments

No comments yet. Be the first!